Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin

Detalles Bibliográficos
Autores principales: Masuda, Daisaku, Yamashita, Shizuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406402/
https://www.ncbi.nlm.nih.gov/pubmed/32009076
http://dx.doi.org/10.5551/jat.ED124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406402/
https://www.ncbi.nlm.nih.gov/pubmed/32009076
http://dx.doi.org/10.5551/jat.ED124

Ejemplares similares